Hyloris Pharmaceuticals has enrolled the first patient in a phase III trial for its oral rinse that controls bleeding during and after procedures in dental patients who are taking anticoagulants.

Experts estimate that 20 percent of women experience excessive or prolonged menstrual bleeding at some time during their lives, particularly as they approach menopause. A new, less invasive procedure ...